Skip to main content
. 2017 Aug 17;16(4):5393–5405. doi: 10.3892/mmr.2017.7275

Table V.

Pathway analysis of the overlap of natural language processing analysis and predicted target genes of microRNA-136-5p.

Title Count P-value Genes
Pathways in cancer 31 1.03×10−13 FGF19, E2F1, E2F3, XIAP, KITLG, FOXO1, FASLG, TCF7L2, PTEN, MMP2, TPM3, CDC42, FOS, BCL2, ITGAV, RAC1, FIGF, FGF2, AKT2, FN1, PRKCA, RET, AR, MSH3, BRAF, CBL, CDK6, CDK4, MAPK1, ETS1, PTCH1
Neurotrophin signaling pathway 13 3.19×10−6 YWHAZ, BRAF, FASLG, IRS1, MAPK1, CDC42, BDNF, PSEN1, BCL2, RAC1, NTRK2, NGFR, AKT2
Prostate cancer 11 5.85×10−6 E2F1, MAPK1, E2F3, AR, BRAF, BCL2, CREB1, FOXO1, PTEN, TCF7L2, AKT2
Melanoma 10 6.45×10−6 E2F1, FGF19, MAPK1, E2F3, BRAF, CDK6, CDK4, FGF2, PTEN, AKT2
Pancreatic cancer 10 7.26×10−6 E2F1, CDC42, MAPK1, E2F3, BRAF, RAC1, CDK6, CDK4, FIGF, AKT2
Glioma 9 2.14×10−5 PRKCA, E2F1, MAPK1, E2F3, BRAF, CDK6, CDK4, PTEN, AKT2
Focal adhesion 15 2.22×10−5 PRKCA, CDC42, MAPK1, CAV1, FLT1, BRAF, XIAP, CCND2, BCL2, ITGAV, RAC1, FIGF, PTEN, FN1, AKT2
Small cell lung cancer 10 2.60×10−5 E2F1, E2F3, XIAP, BCL2, ITGAV, CDK6, CDK4, PTEN, FN1, AKT2
Non-small cell lung cancer 8 6.29×10−5 PRKCA, E2F1, MAPK1, E2F3, BRAF, CDK6, CDK4, AKT2
Bladder cancer 7 1.24×10−4 E2F1, MAPK1, E2F3, BRAF, CDK4, FIGF, MMP2
MAPK signaling pathway 15 4.72×10−4 PRKCA, FGF19, BRAF, MAP2K4, FASLG, CDC42, MAPK1, FOS, DUSP4, BDNF, RAC1, NTRK2, GADD45B, FGF2, AKT2
Chronic myeloid leukemia 5.09×10−4 E2F1, MAPK1, E2F3, BRAF, CBL, CDK6, CDK4, AKT2
Colorectal cancer 8 1.01×10−3 MAPK1, FOS, MSH3, BRAF, BCL2, RAC1, TCF7L2, AKT2
Renal cell carcinoma 7 2.021×10−3 CDC42, MAPK1, BRAF, ETS1, RAC1, FIGF, AKT2
Thyroid cancer 5 2.04×10−3 MAPK1, RET, BRAF, TCF7L2, TPM3
Cell cycle 9 2.47×10−3 E2F1, CDC6, E2F3, YWHAZ, CCND2, PRKDC, CDK6, CDK4, GADD45B
p53 signaling pathway 6 9.20×10−3 CCND2, CDK6, CDK4, GADD45B, CCNG2, PTEN

The pathway analysis was performed in Kyoto Encyclopedia of Genes and Genomes database and there were 33 available pathways. Among them, 17 signaling pathways were significant (P<0.01).